Editorial Board
University of Hasselt, Belgium
| Biography Dr. Jeroen Declercq is a senior postdoc at the Laboratory of Biochemical Neuroendocrinology, Department of Human Genetic, KU Leuven, Belgium. He completed his undergraduate work at the KU Leuven, where he obtained a master of Biochemistry. He completed a second Master of Immunology, signaling transduction and lymphomas at the University Paul Sabatier, Toulouse, France. In 2007, he obtained a PhD student at the Laboratory of Molecular Oncology at the KU Leuven, doing doctoral work with Prof. Wim J.M. Van de Ven. He performed a first postdoctoral training in the Stem Cell Institute Leuven, under the guidance of Prof. Catherine Verfaillie. Currently he works on “Protein biosynthesis, maturation and trafficking in the (regulated) secretary signaling pathway, related to human diseases” in the Laboratory of Prof. John. W.M Creemers. During this postdoctoral training, he also worked for 6 months as a guest scientist in laboratory of Prof. Stefan Lichtenthaler at the Technical University in Munich, Germany. Research Interest
|  |
University of Pennsylvania, USA
| Biography Deepak Nihalani is an Assistant Research Professor in the University of Pennsylvania. He is a member of many professional societies which include ASN (American Society for Nephrology and NKF (National Kidney Foundation). He also serves as an editorial board member for 3 journals and as a reviewer for PLOS One, Dove medical press etc. His peer reviewed publications are more than 20 and has given nearly 20 presentations. His ongoing research has been supported by National Institute of Health (NIDDK). Research Interest
|  |
Emory University School of Medicine, USA
| Biography Dr. Masayoshi Yamaguchi is an Adjunct Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA (2013); Visiting Professor in Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX, USA (2012–2013); Visiting Professor in Department of Pathobiology, College of Veterinary Medicine, The University of Missouri-Columbia, MO, USA (2012). He discovered two novel proteins and genes; cell signaling suppressor protein (named regucalcin; 1978) and transcriptional factor RGPR-p117 (regucalcin gene promoter region-related protein; 2001) in mammalian cells. He is serving as editor and editorial board member of reputed 24 international Journals. He received many honor and awards; Prize for Sato Memorial Fundation (1992, Japan/USA), Senji Miyata Foundation Award 2005 (Japan), Japan Society for Biomedical Research on Trace Elements Award 2007, The Lifetime Achievement Award from International Biographical Centre (IBC) (2004, England), The World Lifetime Achievement Award from American Biographical Institute (2004, USA), The Distinguished Service to Science Award from IBC (2007, England), and many others. Dr. Yamaguchi is listed in various biographies; Who’s Who in the World (2005-, Marquis Who’s Who, USA), Who’s Who in Sciences and Engineering (2004-, Marquis Who’s Who, USA), International Biographical Dictionary (2006-, IBC, England), and others. Research Interest
| .bmp) |
Centre for Global Initiatives, USA
| Biography Dr. Chris Stout is the Founding Director of the Center for Global Initiatives. He is on faculty at the College of Medicine at the University of Illinois and Advisory Board Member to their Center for Global Health. He was appointed by the Secretary of the US Department of Commerce to the Board of Examiners for the Baldrige National Quality Award. He is on the Advisory Board of the American Board of Independent Medical Examiners, and numerous other organizations. He was one of the World Economic Forum’s Global Leaders of Tomorrow, and he was an Invited Faculty in Davos. He is the founder of GordianKnot, LLC, an executive leadership consultancy and he currently runs the Department of Research and Data Analytics for a national sports and rehabilitation medicine organization with $500M in annual revenues.
Dr. Stout authored the highly praised and award–winning three volume set, The New Humanitarians, and is an Amazon Best Selling Author. Additionally, he has published over 300 papers and 35 books. His works have been translated into 8 languages. He has lectured world-wide, visited 6 continents and over 85 countries. Dr. Stout was educated at Purdue, The University of Chicago, Forest Institute, and was a post-doc fellow at Harvard Medical School. He has won 5 Humanitarian Awards and received four additional doctorates (honoriscausa). He endowed a scholarship in perpetuity at Purdue University‘s School of Engineering and Technology, and is an active Angel Investor and Advisory to numerous start-ups. Research Interest
|  |
Yokohama Rosai Hospital, Japan
| Biography Dr. Tetsuo Nishikawa is a president in Yokohama Rosai Hospital. He worked as a clinical professor in Chiba University. He was awarded with “Distinguished Endocrinologist award-2009” from Japan Endocrine Society. He is a member of many scientific societies of both USA and Japan. He has many scientific publications and has attended nearly 20 conferences from past 3 years. Research Interest Hormonal steroids
Metabolic disorders
|  |
UAE University, UAE
| Biography Prof. Amin is a graduate faculty at UAE University who supervised many graduate theses. He earned his PhD from University of Illinois at Chicago and received a postdoctoral training at University of Pennsylvania School of Medicine. After joining UAEU Prof. Amin’s focus was redirected to the field of preventive medicine. His lab is interested in natural product's role in treating diabetes and cancer. He has published many articles, reviews and book chapters in reputable journals. He serves on the editorial board and as a reviewer of many international journals. Prof. Amin is also the recipient of many national and international awards. Research Interest
|  |
University of California Irvine, USA
| Biography Dongbao Chen is a Professor and Director of Perinatal Research, Division of Maternal-Fetal Medicine, Department of Obstetrics & Gynecology and Pathology, University of California, Irvine; Faculty, Cellular & Molecular Biosciences Graduate Program, University of California, Irvine. B.S. in Animal Sciences and M.S. in Animal Reproduction, Northwest Agricultural University, Shaanxi, China (1985 and 1988); Ph.D. in Reproductive Physiology, China Agricultural University, Beijing, China (1991); Post doctoral Fellow in Reproductive Physiology, Baylor College of Medicine, Houston, TX (1993–1995); Lalor Foundation Postdoctoral Fellow in Molecular Endocrinology, The Women's Research Institute, University of Kansas School of Medicine-Wichita, Wichita, KS (1995–1998). Research Interest Cellular and molecular regulation of vasodilatation and angiogenesis at the maternal-fetal and placental interface with a focus on reactive nitrogen and oxygen species as well as reactive sulfides. |  |
Austrian Academy of Sciences, Austria
| Biography Sergei V Pereverzev is a Professor and Research supervisor in Research Group "Inverse Problems" of the Johann Radon Institute for Computational and Applied Mathematics. His area of expertise includes Data-Based Modeling and Prediction Of Blood Glucose Dynamics. He is a co-developer of the fully adaptive regularized learning (FARL) methodology for predicting blood glucose concentration and the prediction-error grid analysis (PRED-EGA) for the assessment of glucose predictors. He is also the author of over one hundred scholarly articles, two monographs, and serves as a member of editorial boards of 6 journals. Research Interest
|  |
Medtronic MiniMed, USA
| Biography Barry completed Ph.D in Engineering in 1999, focusing on Cardiac Doppler ultrasound signal processing. Barry has been developing biomedical algorithms for medical devices over this past 17 years in areas such as cardiac monitoring, neurology, activity and respiratory disturbance for sleep apnea, chronic cough and diabetes. His current work is in the development of therapy management and continuous glucose monitoring algorithms for the application to closed loop control for an artificial pancreas. He currently works for Medtronic Diabetes, Northridge, CA, as a Research Director, managing a team of scientists developing the closed loop artificial pancreas. Barry is a Medtronic Technical Fellow and a member of Sigma Xi, the Scientific Research Organization. He is a reviewer for a number of biomedical and diabetes journals, and is on the editorial board of the Journal of Diabetes and Metabolism. Research Interest
|  |
Stanford University School of Medicine, USA
| Biography Laurence Katznelson, MD received his medical degree from the University of California, Los Angeles and performed his internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania, Philadelphia. He then performed a fellowship in Endocrinology and Metabolism at the Massachusetts General Hospital, Boston. He is currently the Medical Director of the Pituitary Center at Stanford University Medical Center, Stanford, California. He is a Professor of Neurosurgery and Medicine at Stanford University School of Medicine and Program Director for the Endocrinology fellowship training program. He is a member of the Editorial Board for Frontiers in Medicine and is an ad hoc reviewer for the Journal of Clinical Endocrinology and Metabolism.
Research Interest
|  |
Eli Lilly and Company, USA
| Biography Dr. Chadi Saifan is a visiting scientist in Eli Lilly and company located in Indianapolis, USA. He has completed his Doctor of Medicine from Lebanese University. He is a member of many professional organizations which include Society of Hospital Medicine, American Medical Association and American Red Cross. He is awarded with research fellow award and has more than 20 presentations and scientific publications. Research Interest
|  |
Tohoku University, Japan
| Biography Dr. Nonogaki is a specialist in Diabetes care and Internal medicine. He has obtained PhD in Endocrinology, Metabolism, and Diabetes. Then, he worked as a Post doc Fellow at the University of California, San Francisco and the Scripps Research Institute, La Jolla. During this period, his research was mainly focused on “the role of the central nervous system in the regulation of hepatic glucose production”, “cytokines and lipid metabolism”, and “ brain serotonin systems and energy homeostasis”. He found the novel evidence in the dissociated pathways of serotonin 5-HT2C receptor and leptin in the central regulation of appetite and obesity, and proposed a novel physiological theory of “Central dissociated regulation of feeding and autonomic neural circuits”. Current studies are to determine the physiological mechanisms and potential treatment for obesity, diabetes and their complications. Dr. Nonogaki is also developing novel medical devices for hypertension and atherosclerosis. Research Interest
|  |
University of Siena, Italy
| Biography Dr. Luigi Gennari received his MD degree at the University of Siena (1993), an advanced degree in Endocrinology and Metabolic Diseases at the University of Florence (1998), and a PhD in Endocrinology (2003). Since October 2002 he was serving as Assistant Professor of Internal Medicine at the Metabolic Disease Unit, Dept. Medicine, Surgery and Neurosciences, University of Siena. In 2000, he received the “IOF-Servier Young Investigator Research Fellowship” and in 2002 the “Young Investigator Award for Innovative Research” from the International Osteoporosis Foundation. In 2004, he was recipient of the American Society for Bone and Mineral Research-Young Investigator Award, also was appointed as a member of the Advisory Medical Panel of the Paget Foundation. In 2005, he was recipient of the “Forum in Bone and Mineral Research 2005” award, and in 2009 was recipient of the “John G. Haddad, Jr Research Award” of the Paget Foundation. He is member of the Editorial Boards of Osteoporosis International and the Journal of Bone and Mineral Research. He is author of several publications in peer reviewed journals and of chapters in several book on these and other related topics. In the same fields, he has lectured at both national and international meetings and received numerous research grants. Research Interest
| .JPG) |
Instituto Mexicano del Seguro Social, Mexico
| Biography Arturo Zarate completed his research fellowship in gynecologic endocrinology at the Medical College of Georgia, Augusta GA, another research fellowship at the Southwestern Foundation in San Antonio TX, and finally at the University of California in Torrance. He received his doctorate in Medical Sciences from the National University of Mexico. At his return to Mexico he became Professor and Chairman of the Department of Endocrinology, then Director of National Research Program in the Instituto Mexicano Seguro Social. He has published over 400 scientific papers in various medical and scientific journals as well as seventeen chapters in book chapters. He was a friend and close collaborator of the pioneer medical studies with Nobel Laureate Andrew V. Schally using the hypothalamic hypophysiotropic hormones. He is a Member of the Mexican Academy of Medicine, Mexican Academy of Sciences, Endocrine Society, and Society for Gynecologic Investigation, Mexican Society of Endocrinology as well as Honorary Member of several international scientific societies. He has received distinguished Achievement Awards by the Mexican Public Health Ministry, the Mexican Endocrine Society and the National Academy of Medicine. At present he is Emeritus Investigator Research of Mexico and Emeritus Research at the Instituto Mexicano del Seguro Social. His present positive in the chair at the Endocrine Research Unit and Emeritus Professor of Endocrinology at the National University of Mexico and Emeritus Member of him National Investigators Council. Research Interest
|  |
University of Pennsylvania, USA
| Biography Dr. Abbas F Jawad got his Master of Science and PhD degrees from the University of Pittsburgh, Graduate School of Public Health. He joined the rank of Associate Professor of Biostatistics in Pediatrics, University of Pennsylvania, School of Medicine, Department of Pediatrics at the Children’s Hospital of Philadelphia in 1993.
He has extensive experience in data coordinating, management and statistical analyses for numerous important clinical studies in children. He has been providing biostatistical support for medical pediatric research for more than 20 years in regard to experiment designs, statistical analyses and publication of results in peer reviewed journals. He has particular expertise in clinical trials studies and in the methodology of longitudinal study designs, measurement errors, and effect of initial measurement on the estimation of treatment effect.
He has significant experience in collaborative biomedical research and in the development and evaluation of methods for the analysis of large datasets. He has more than 107 publications in the field of clinical research. Research Interest
|  |
University of North Carolina, North Carolina
| Biography Dr. Anthony C. Hackney is a professor of Exercise Physiology and Nutrition at the University of North Carolina at Chapel Hill. He directs the Applied Physiology laboratory and the Endocrine Research Group in the department of Exercise & Sport Science. He is also a professor in the Department of Nutrition (Nutrional Biochemistry) in the Gillings School of Global Public Health. Research Interest
|  |
Aseer Diabetes Center, Saudi Arabia
| Biography
Kamran M.A. Aziz completed his medical graduation at Dow University of Health Sciences (SMC) in 1998, and post-graduation in diabetic medicine at Baqai Institute of Diabetes and Endocrinology, Baqai University Hospital in 2003 (Karachi, Pakistan). Research Interest
|  |
National Institute of Dental and Craniofacial Research, USA
| Biography Dr. Tao Cai, MD/PhD, is a Staff Scientist at NIDCR, NIH, Bethesda, Maryland, USA (2001-); Visiting professor in Chinese Academy of Sciences at Beijing. He is interested in understanding how insulin production and secretion in pancreatic islet beta cells are regulated by vesicle-associated proteins and transcription factors. In recent years, Dr. Cai has applied a combination of classical genetic approach and novel next-generation sequencing technique to identify and characterize the genes that cause human diseases, many of the mutations are associated with uncharacterized rare disorders. Research Interest
|  |
King Abdullah International Medical Research Center, Saudi Arabia
| Biography
Dr. Sameer Mohammad is a research scientist in the department of Experimental Medicine, King Abdullah International Medical Research Center (KAIMRC) Saudi Arabia. He completed his PhD at Jawaharlal Nehru University (JNU), New Delhi, India, followed by post-doctoral training in the University of Arkansas for Medical Sciences (UAMS), Little Rock, USA. He worked in Weill Medical College of Cornell University, New York to understand the molecular mechanism of insulin resistance and Type 2 Diabetes. He has authored and co-authored several papers in international journals of repute. Research Interest
|  |
Queen Elizabeth Hospital, China
| Biography Dr. William Cho is a Biomedical Scientist in Queen Elizabeth Hospital. His main research interests have been focusing on cancer studies utilizing high-throughput technologies to discover biomarkers for cancer diagnosis, treatment prediction and prognostication. He is a Chartered Scientist granted by the Science Council (UK), a Registered Chinese Medicine Practitioner (HK), Guest Professor of a number of Universities and a Fellow Member of several institutes, including the Institute of Biomedical Science (UK), Hong Kong Institute of Biomedical Science and Hong Kong Society for Molecular Diagnostic Sciences. Dr Cho has published over 200 peer-reviewed papers (Lancet Oncology, Clinical Cancer Research, Clinical Chemistry, Annual Oncology, etc) covering cancer biomarkers, proteomics, microRNAs, Chinese medicine and plenty of books including "MicroRNAs in cancer translational research", "An omics perspective on cancer research", "Supportive cancer care with Chinese medicine", etc. He serves as the editor-in-chief, editor and associate editor of a number of international medical journals. He is also an international renowned grant reviewer of the Hope Funds for Cancer Research (USA), Cancer Research (UK), MRC Research Grant (UK), Health Research Board (Ireland), Science Foundation (Ireland), Istituto Toscano Tumori (Firenze), The Foundation Fournier-Majoie for Innovation (Brussels), National Medical Research Council (Singapore), The Medical Research Council (South Africa), and Academia Sinica Investigator Award (Taiwan), etc. Research Interest
He is specialized in molecular oncology, Chinese herbal medicine, pathology, clinical cancer research, pharmacology, molecular diagnostics, tumor marker discovery, cancer therapeutics, proteomics, bioinformatics, diabetes mellitus and drug target discovery. |  |
S.G. Moscati, Avellino, Italy
| Biography Cesare Gridelli, MD, is currently Chief of Division of Medical Oncology at the “S.G. Moscati” Hospital, Avellino (Italy). He has been from December 2003 to February 2016 Director of Department of Oncology/Hematology at the same institution. He earned his medical degree and residencies in Internal Medicine and then in Medical Oncology at the “Federico II” University of Naples (Italy). Since 1993, Vice-Chief of Division of Medical Oncology B, National Cancer Institute of Naples. Since 2001, Chief of Day Hospital Chemotherapy Unit at the same Institute. He is a member of several national (AIOM, AIOT, CTPG) and international scientific societies (ASCO, ESMO, IASLC). He is President of the Italian Association of Thoracic Oncology (AIOT). He is a past member of the Foundation Council of the European Thoracic Oncology Platform (ETOP). He is a member of Advisory Board of scientific journals and of several expert panels. He has been invited as a speaker at international conferences and educational activities of oncology societies (ASCO, ESMO etc.). He gave 2 oral presentation and 5 talks as the faculty member at the annual ASCO meetings. He is author or co-author of more than 750 papers, of which more than 370 extended papers published in international indexed journals, and several chapters of books. His papers have about 15.800 citations on international indexed journals. He has an h-index of 60. On November 2013, the American agency Expertscape (Palo Alto, California) appointed Dr. Gridelli at the first place among the top world experts on lung cancer. Research Interest His expertise areas are lung cancer and cancer in the elderly. He is deeply involved in the clinical development of new anticancer targeted therapies and immunotherapy. He has been the principal investigator of several national and international clinical trials. |  |
University of Florence, Italy
| Biography He (born 1933) directed the Gastroenterology Research Unit, a third level referral center in the department of Pediatrics of the University of Florence (Meyer hospital) from 1965 to 2000. In Tuscany He first diagnosed celiac disease by the Watson capsule. He worked at the Cornell University for a joined research with the University of Florence on energy expenditure in children. A long term strategy was designed with Giuliano Parrini, prof. of Physics (Firenze, It), Andrea Giommi, prof. of Statistics (Firenze, It), and Cutberto Garza, Boston College, Rector. Three students came from Amsterdam Medical Center to learn “Initial Hunger (IH)”. The Unit published 150 scientific articles, more than 50 in international Press. Research Interest Loss of hunger sensations as cause of alimentary diabetes and malnutrition |  |
University of California, U.S.A
| Biography Dr. Khue Vu Nguyen (born in Ha Noi, Viet Nam) is currently Full Project Scientist in the Departments of Medicine and Pediatrics, University of California, San Diego, School of Medicine, San Diego, California, U.S.A. He has studied at University Louis Pasteur, Strasbourg, France: B.S. in Biochemistry, M.S. in Molecular Biology, Ph.D. in Macromolecular Physical Chemistry, and Ph.D. in Physical Sciences (Doctorate d’états Sciences Physiques). He has worked as Scientist in different French and U.S. Research Institutions and Companies. He is author and co-author of numerous publications and holder of many patents. He is listed in Who’s Who in the World, Who’s Who in America, etc. He is member of different academic organizations such as American Society for Microbiology, American Chemical Society. He is invited reviewer of different scientific journals such as Molecular Genetics and Metabolism, AGE: Journal of the American Aging Association. He is also editorial board member of different scientific journals such as International Journal of Medicine and Molecular Medicine, Open Access Journal of Endocrine and Metabolic Diseases. He is Scientist Reviewer for grant proposals of the Metabolic Disease Two (MB-2) of the Peer Review Medical Research Program (PRMRP) for the U.S. Department of Defense Congressionally Directed Medical Research Programs (CDMRP). Current research includes genetic diseases, neurodevelopment and neurodegenerative disorders, and cancer.
neurodegenerative disorders, and cancer.Dr. Khue Vu Nguyen (born in Ha Noi, Viet Nam) is currently Full Project Scientist in the
Departments of Medicine and Pediatrics, University of California, San Diego, School of
Medicine, San Diego, California, U.S.A. He has studied at University Louis Pasteur,
Strasbourg, France: B.S. in Biochemistry, M.S. in Molecular Biology, Ph.D. in Macromolecular
Physical Chemistry, Ph.D. in Physical Sciences (Doctorat d’Etat es Sciences Physiques). He
has worked as Scientist in different French and U.S. Research Institutions and Companies. He
is author and co-author of numerous publications and holder of many patents. He is listed in
Who’s Who in the World, Who’s Who in America, etc. He is member of different academic
organizations such as American Society for Microbiology, American Chemical Society. He is
invited reviewer of different scientific journals such as Molecular Genetics and Metabolism,
AGE: Journal of the American Aging Association. He is also editorial board member of different
scientific journals such as International Journal of Medicine and Molecular Medicine, Open
Journal of Endocrine and Metabolic Diseases. He is Scientist Reviewer for grant proposals of
the Metabolic Disease Two (MB-2) of the Peer Review Medical Research Program (PRMRP) for
the U.S. Department of Defense Congressionally Directed Medical Research Programs
(CDMRP). Current research includes genetic diseases, neurodevelopmental and
neurodegenerative disorders, and cancer.
Research Interest
|  |
Maulana Azad Medical College, India
| Biography Currently, he is working as an Associate Professor, Department of Biochemistry, G.B.Pant Institute of Postgraduate Medical Education & Research (GIPMER), associated to Maulana Azad Medical College, Govt of NCT of Delhi. He is also serving as Chair, International Core Committee of IFCC Task Force for Young Scientists (IFCC-TF YS). He is Qualified NABL Assessoras per ISO 15189: 2012 for Clinical Laboratory and has Advanced Training in Supply Chain Management as well. He has completed MBBS from Maulana Azad Medical College, Delhi University in 2002 and MD (Biochemistry) from Lady Hardinge Medical College, Delhi University in 2007. Further, to increase the proficiency in management, he pursues the Business Administration & Hospital Management. Due to keen interest in research and laboratory medicine, he has been awarded Thrice for his research work in “Postmenopausal Women CAD Risk & Gene Polymorphism” and “Diabetic CAD Risk” and received Five Awards & Travel Grants at International level. He has more than 30 research papers, 4 chapters, 2 books and 25 abstracts to his credit in reputed National & International journals. Research Interest
|  |
